Valeo Pharma (TSX:VPH) Other Financing : C$1.76 Mil (TTM As of Jul. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Valeo Pharma Other Financing?

Valeo Pharma's Other Financing for the three months ended in Jul. 2024 was C$-0.19 Mil.

Valeo Pharma's Other Financing for the trailing twelve months (TTM) ended in Jul. 2024 was C$1.76 Mil.

Valeo Pharma Other Financing Historical Data

The historical data trend for Valeo Pharma's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valeo Pharma Other Financing Chart

Valeo Pharma Annual Data

Trend

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Other Financing

Get a 7-Day Free Trial

0.34

0.09

-3.15

-0.30

Valeo Pharma Quarterly Data
	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24
Other Financing	Get a 7-Day Free Trial															1.30	2.32	-0.16	-0.22	-0.19

Valeo Pharma Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Jul. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$1.76 Mil.

Valeo Pharma Other Financing Related Terms

Thank you for viewing the detailed overview of Valeo Pharma's Other Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Valeo Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Valeo Pharma Inc (TSX:VPH) » Definitions » Other Financing

Comparable Companies

Traded in Other Exchanges

VPHIF:USA VP2:Germany

Address

16667, Hymus Boulevard, Kirkland, QC, CAN, H9H 4R9

Website

https://www.valeopharma.com

Valeo Pharma Inc is a Canadian specialty pharmaceutical company focused on acquiring either through acquisitions, in-licensing, or similar arrangements. The company operates in two divisions: Branded prescription products and hospital specialty products. Its product portfolio includes medicines for Respiratory/Allergy, Ophthalmology, Neurology, and Oncology.

Executives

Luc Mainville	Senior Officer
100079 Canada Inc.	10% Security Holder
Richard J. Mackay	Director, Director or Senior Officer of 10% Security Holder
Steve Saviuk	Director, Director or Senior Officer of 10% Security Holder, Senior Officer
Jeffrey Michael Skinner	Senior Officer
Frederic Fasano	Director
Guy Paul Allard	Director or Senior Officer of 10% Security Holder, Senior Officer
Marc François Léger	Senior Officer

Valeo Pharma Headlines

No Headlines